Diality Closes $24 Million of Series B2 Financing
The Series B2 round of funding will be used for activities to support 510(k) clearance, preparing for the home clinical study and to build a U.S. commercial organization.
The Series B2 round of funding will be used for activities to support 510(k) clearance, preparing for the home clinical study and to build a U.S. commercial organization.